“Reelin” in a new treatment for multiple sclerosis – UT Southwestern Medical Center

Anti-Reelin is a therapeutic approach that selectively targets the vascular barrier, blocking infiltration of inflammatory cells, demyelination and, consequently, paralysis.

In an animal model of multiple sclerosis (MS), decreasing the amount of a protein made in the liver significantly protected against development of the disease’s characteristic symptoms and promoted recovery in symptomatic animals, UTSW scientists report.

The findings, published online today by Science Translational Medicine, could lead to a new treatment strategy for this neurological disease and other conditions marked by chronic inflammation.

Click here to read full article https://www.utsouthwestern.edu/newsroom/articles/year-2020/reelin-in-a-new-treatment-for-multiple-sclerosis.html

Font Resize